TONIX PHARMACEUTICALS HOLDING CORP. 509 Madison Avenue, Suite 306 New York, New York 10022 October 15, 2013
Exhibit 10.01
TONIX PHARMACEUTICALS HOLDING CORP.
509 Madison Avenue, Suite 306
New York, New York 10022
October 15, 2013
VIA EMAIL
Lederman & Co., LLC
245 E. 93rd St. 14E
New York, NY 10022
Attn: Seth Lederman, Managing Member
| Re: | Amendment to Consulting Agreement |
Dear Mr. Lederman:
This letter shall serve as an amendment to the consulting agreement entered dated as of June 4, 2010 between Lederman & Co., LLC (“Lederman & Co.”) and Tonix Pharmaceuticals, Inc., as amended on December 9, 2010 and February 1, 2012 (the “Agreement”). Capitalized terms used but not defined herein shall have the meaning ascribed to them in the Agreement. Section 3(b) of the Agreement is hereby amended and replaced in its entirety with the following:
“During the Consulting Period, the Consultant’s compensation shall be $325,000 per annum, or such greater amount as the Board may designate from time to time (the "Consulting Fees"). Consulting Fees shall be payable in monthly installments”
The foregoing amendment shall be effective as of October 15, 2013.
TONIX PHARMACEUTICALS HOLDING CORP.
/s/ LELAND GERSHELL
By: Leland Gershell
Title: Chief Financial Officer
Accepted to and agreed this
15th day of October, 2013:
LEDERMAN & CO., LLC
/s/ SETH LEDERMAN
By: Seth Lederman
Title: Managing Member
